What are the possible causes of a main pulmonary artery measuring 3 cm (dilated) on coronary computed tomography angiography (CTA)?

Main Pulmonary Artery Dilated to 3 cm: Differential Diagnosis

A main pulmonary artery measuring 3.0 cm on coronary CTA is definitively dilated and warrants systematic evaluation for pulmonary hypertension and other underlying causes. 1

Diagnostic Threshold and Significance

The finding of a 3.0 cm main pulmonary artery (MPA) meets the established threshold for dilation, as MPA ≥3.0 cm or equal to the ascending aorta diameter should be reported as dilated 1. The 90th percentile cutoff values from the Framingham Heart Study are 29 mm in men and 27 mm in women 1. An MPA diameter of 29 mm demonstrates 87% sensitivity and 89% specificity with a 97% positive predictive value for pulmonary hypertension 2.

Primary Differential Diagnoses

1. Pulmonary Hypertension (Most Common)

This is the leading cause of MPA dilation and includes multiple subtypes 1:

• Idiopathic pulmonary arterial hypertension (IPAH) - represents at least 40% of PAH cases 1
• Chronic thromboembolic pulmonary hypertension (CTEPH) - occurs in <1% of patients following documented PE 1
• Left heart disease-related PH - particularly diastolic dysfunction 3
• Lung disease-related PH - from interstitial lung disease, emphysema, sarcoidosis 2
• Connective tissue disease-associated PH - especially systemic sclerosis, HIV, sickle cell disease 1

Key imaging clues for pulmonary hypertension:

• MPA to ascending aorta ratio >1.0 (96% positive predictive value) 1, 2
• Right ventricular enlargement with RV/LV lumen ratio ≥1 2
• Interventricular septal flattening 2
• RV free wall thickness ≥6 mm 2
• Segmental PA to bronchus ratio >1:1 2
• Pericardial effusion or thickening 2

2. Chronic Thromboembolic Disease

Look specifically for 2, 4:

• Eccentric thrombus within pulmonary arteries
• Abrupt vessel cutoff or narrowing
• Linear webs or bands within arteries
• Mosaic lung attenuation from perfusion abnormalities
• Bronchial artery enlargement >1.5 mm

Critical point: V/Q scanning has 96-97% sensitivity and 90-95% specificity for CTEPH, superior to CT alone which can miss the diagnosis 4. If CTEPH is suspected, V/Q scan is mandatory 5.

3. Connective Tissue Disorders/Arteriopathy

• Marfan syndrome - associated with PA dilatation, aortic root aneurysms 6
• Loeys-Dietz syndrome - arterial tortuosity with PA aneurysms 6
• Ehlers-Danlos syndrome 6

4. Isolated Pulmonary Valve Stenosis

Recent evidence shows 67.2% of patients with isolated PV stenosis present with MPA dilatation, with 16.8% having giant dilatation 7. This represents a hemodynamic consequence rather than arteriopathy, with a benign course and no recorded dissections 7.

5. Idiopathic Dilatation of Pulmonary Artery (IDPA)

A rare diagnosis of exclusion with incidence as low as 0.007% 8. Requires excluding all other causes of PA enlargement 9, 8.

6. Advanced Fibrotic Lung Disease

Retractile forces on the mediastinum can cause MPA dilation independent of pulmonary hypertension 1. Anthracofibrosis specifically shows mean PAD of 33 mm 10.

Critical Complications to Assess

Left main coronary artery (LMCA) compression - uncommon but life-threatening complication when MPA is severely dilated 2, 11, 12. Look for:

• Extrinsic compression of LMCA on CTA 2
• Anginal symptoms or acute coronary syndrome 11, 12
• May present without typical angina 11

Recommended Diagnostic Algorithm

1. Review the coronary CTA systematically:

   • Measure MPA to ascending aorta ratio
   • Assess RV size and function
   • Look for thromboembolic disease features
   • Evaluate lung parenchyma for fibrosis/emphysema
   • Check for LMCA compression

2. Obtain transthoracic echocardiography to:

   • Estimate pulmonary artery systolic pressure
   • Assess RV function and size
   • Evaluate for valvular disease (especially PV stenosis)
   • Screen for congenital heart disease

3. If PH suspected (PA pressure >40 mmHg systolic):

   • Perform V/Q scan to exclude CTEPH 4
   • Consider right heart catheterization for definitive diagnosis 5
   • Measure pulmonary capillary wedge pressure to exclude left heart disease 3, 5

4. Screen for underlying conditions:

   • Connective tissue disease markers
   • HIV testing
   • Pulmonary function tests
   • Sleep study if indicated

Common Pitfalls

• Do not rely on CT alone to exclude CTEPH - V/Q scanning is superior 4
• Parenchymal lung disease reduces the sensitivity/specificity of MPA diameter for diagnosing PH 2
• Echocardiography often underestimates MPA diameter compared to CT/MRI, particularly in giant dilatation (50% underestimation) 7
• Normal CT angiogram does not exclude CTEPH when V/Q scan shows abnormalities 5

Right heart catheterization remains the gold standard for confirming pulmonary hypertension before initiating therapy 2, requiring mean PA pressure >25 mmHg and PVR ≥3 Wood units 5.